SI-BONE (NASDAQ:SIBN) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS

SI-BONE (NASDAQ:SIBN) released its quarterly earnings data on Monday. The company reported ($0.22) EPS for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.04, Yahoo Finance reports. SI-BONE had a negative return on equity of 25.14% and a negative net margin of 29.93%. The business had revenue of $39.97 million for the quarter, compared to the consensus estimate of $38.95 million. During the same quarter in the prior year, the business posted ($0.30) EPS.

SI-BONE Stock Up 1.7 %

Shares of NASDAQ SIBN traded up $0.24 during trading on Tuesday, reaching $14.28. 254,420 shares of the stock were exchanged, compared to its average volume of 404,874. The business’s 50-day moving average price is $14.04 and its 200 day moving average price is $15.95. The company has a market capitalization of $588.48 million, a price-to-earnings ratio of -13.30 and a beta of 1.20. SI-BONE has a twelve month low of $11.76 and a twelve month high of $24.33. The company has a quick ratio of 8.75, a current ratio of 9.76 and a debt-to-equity ratio of 0.22.

Analyst Ratings Changes

SIBN has been the subject of a number of recent research reports. Truist Financial decreased their price objective on SI-BONE from $20.00 to $18.00 and set a “buy” rating for the company in a research report on Tuesday. Morgan Stanley decreased their price target on SI-BONE from $21.00 to $19.00 and set an “overweight” rating for the company in a report on Tuesday. Needham & Company LLC dropped their price objective on shares of SI-BONE from $27.00 to $19.00 and set a “buy” rating on the stock in a research note on Tuesday. Finally, JMP Securities restated a “market outperform” rating and issued a $32.00 target price on shares of SI-BONE in a research note on Tuesday, May 7th. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, SI-BONE has an average rating of “Buy” and a consensus target price of $23.00.

Insider Activity at SI-BONE

In other SI-BONE news, insider Anthony J. Recupero sold 3,941 shares of the company’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $15.10, for a total value of $59,509.10. Following the completion of the transaction, the insider now directly owns 247,592 shares of the company’s stock, valued at approximately $3,738,639.20. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other SI-BONE news, insider Anthony J. Recupero sold 3,941 shares of SI-BONE stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $15.10, for a total transaction of $59,509.10. Following the sale, the insider now directly owns 247,592 shares in the company, valued at approximately $3,738,639.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Anthony J. Recupero sold 3,309 shares of the stock in a transaction that occurred on Tuesday, July 2nd. The shares were sold at an average price of $12.92, for a total value of $42,752.28. Following the transaction, the insider now owns 243,629 shares of the company’s stock, valued at $3,147,686.68. The disclosure for this sale can be found here. In the last three months, insiders sold 11,613 shares of company stock valued at $167,568. Corporate insiders own 5.40% of the company’s stock.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.